News and Events

RANCHO CORDOVA, Calif., April 3, 2020 — ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy field, announced today that it was featured on a CBS 13 news segment titled, “Different Kind of Coronavirus Test”, regarding the Company’s SARS-CoV-2 (COVID-19) IgM/IgG Antibody Fast Detection Kit … Continued

ThermoGenesis’ Rapid COVID-19 Serological Test Kit Featured on FOX40 News Story Titled: “Rancho Cordova Company Develops Antibody Test to Detect COVID-19 in Minutes”  RANCHO CORDOVA, Calif., April 2, 2020 — ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy field, announced today that it was … Continued

ThermoGenesis Announces that it has Notified the FDA of its Intent to Distribute the Company’s Rapid COVID-19 Point-of-Care Test Kit RANCHO CORDOVA, Calif., March 31, 2020 — ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy field, announced today that it has notified the U.S. Food … Continued

RANCHO CORDOVA, Calif., March 27, 2020 — ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy field, today announced that it closed its previously announced registered direct offering for the purchase and sale of 1,000,002 shares of the Company’s common stock, at a … Continued

RANCHO CORDOVA, Calif., March 25, 2020 — ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy field, today announced that it has entered into definitive agreements with several healthcare-focused institutional investors for the purchase and sale of 1,000,002 shares of the company’s common … Continued

Net Revenues Increased 35%; Gross Profit Up 156%, Year-over-Year Conference Call to be Held Today at 1:30 p.m. PDT/4:30 p.m. EDT   RANCHO CORDOVA, Calif., March 24, 2020 — ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy field, today announced financial and … Continued

Conference Call to be Held on March 24, 2020 RANCHO CORDOVA, Calif., March 18, 2020 — ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy field, today announced that the Company will release its financial results for the year ended December 31, 2019 and … Continued

$3.0 Million of Outstanding Balance Converted into Common Stock RANCHO CORDOVA, Calif., February 19, 2020 — ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy field, today announced that on February 13, 2020, the Company received notice from Boyalife Asset Holding II, Inc. to … Continued

RANCHO CORDOVA, Calif., Jan. 3, 2020 — ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy field, today announced that ImmuneCyte Life Sciences, Inc. (“ImmuneCyte”), an 80/20 joint venture between HealthBanks Biotech (USA) and ThermoGenesis, has closed a $3.0 million equity investment with … Continued